Arcadia Biosciences gets Nasdaq notice for falling below $2.5 million stockholders’ equity requirement

Arcadia Biosciences said Nasdaq notified the company on Aug. 31, 2026 that it was not in compliance with the exchange’s $2.5 million minimum stockholders’ equity requirement.

• Stockholders’ equity was $633,000 as of June 30, 2026, below the requirement in Nasdaq Listing Rule 5550(b)(1).
• The company said failure to meet alternative listing standards left it out of compliance with Nasdaq Capital Market continued listing rules.
• Shares remain listed for now, and a compliance plan is due within 45 days, by Oct. 15, 2026.
• Nasdaq may grant up to a 180-day extension if the plan is accepted; if rejected, the company can appeal to a hearings panel.